Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co‐primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Platzbecker, Uwe, Götze, Katharina S., Kiewe, Philipp, Germing, Ulrich, Mayer, Karin, Radsak, Markus, Wolff, Thomas, Chromik, Joerg, Sockel, Katja, Oelschlägel, Uta, Haase, Detlef, Illmer, Thomas, Al-Ali, Haifa Kathrin, Silling, Gerda, Reynolds, Joseph G., Zhang, Xiaosha, Attie, Kenneth M., Shetty, Jeevan K., Giagounidis, Aristoteles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671752/
https://www.ncbi.nlm.nih.gov/pubmed/35998303
http://dx.doi.org/10.1200/JCO.21.02476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671752/
https://www.ncbi.nlm.nih.gov/pubmed/35998303
http://dx.doi.org/10.1200/JCO.21.02476

Ejemplares similares